Disclosures Markus A. Rose has received research funding and speaker's fees from Wyeth/Pfizer, Germany.
The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe
Article first published online: 19 JUL 2013
© 2013 The Authors. International Journal of Clinical Practice published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
International Journal of Clinical Practice
Volume 68, Issue 1, pages 8–19, January 2014
How to Cite
Rose, M. A., Christopoulou, D., Myint, T. T. H. and de Schutter, I. (2014), The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe. International Journal of Clinical Practice, 68: 8–19. doi: 10.1111/ijcp.12234
Dina Christopoulou is an employee of Pfizer Ltd, UK.
Tin Tin Htar Myint is an employee of Pfizer Pharmaceuticals, France.
Iris de Schutter has been an invited speaker for Pfizer and has participated in advisory boards for GlaxoSmithKline Biologicals and Pfizer in the past 3 years.
Linked Comment: Stein. Int J Clin Pract 2014; 68: 2–3.
- Issue published online: 17 DEC 2013
- Article first published online: 19 JUL 2013
- Manuscript Accepted: 19 JUN 2013
- Manuscript Received: 1 MAR 2013
This article has been cited by:
- 1Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice, The Pediatric Infectious Disease Journal, 2014, 33, 8, 858, , , ,